Edition:
United Kingdom

Benitec Biopharma Ltd (BNTC.OQ)

BNTC.OQ on NASDAQ Stock Exchange Capital Market

2.53USD
18 May 2018
Change (% chg)

$0.01 (+0.40%)
Prev Close
$2.52
Open
$2.52
Day's High
$2.53
Day's Low
$2.50
Volume
370
Avg. Vol
4,304
52-wk High
$4.15
52-wk Low
$1.85

Select another date:

Mon, Apr 30 2018

BRIEF-Benitec Biopharma Launches Entitlement Offer And Placement

* LAUNCHED ENTITLEMENT OFFER TO ELIGIBLE SHAREHOLDERS AND INSTITUTIONAL PLACEMENT TO HIGHBRIDGE CAPITAL MANAGEMENT LLC

BRIEF-Benitec Biopharma Seeks Trading Halt

* SEEKS TRADING HALT PENDING ANNOUNCEMENT REGARDING CAPITAL RAISING Source text for Eikon: Further company coverage:

BRIEF-Benitec Biopharma ‍Says U.S. FDA Granted Orphan Drug Designation To BB-301​

* ‍U.S. FDA HAS GRANTED ORPHAN DRUG DESIGNATION TO BB-301 FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY(OPMD)​ Source text for Eikon: Further company coverage:

BRIEF-Benitec Biopharma Posts Qtrly ‍Loss Of A$2.9 mln

* QTRLY ‍LOSS OF A$2.9 MILLION VERSUS PROFIT OF A$0.8 MILLION​ Source text for Eikon: Further company coverage:

Select another date: